R. Saez et al., Chronic exposure to ammonia alters pathways modulating phosphorylation of microtubule-associated protein 2 in cerebellar neurons in culture, J NEUROCHEM, 73(6), 1999, pp. 2555-2562
Hyperammonemia is considered the main cause for the neurological alteration
s found in hepatic failure. However, the mechanisms by which high ammonia l
evels impair cerebral function are not well understood. It has been shown t
hat chronic hyperammonemia impairs signal transduction pathways associated
with NMDA receptors and also alters phosphorylation of some neuronal protei
ns. The aim of the present work was to analyze the effects of chronic expos
ure to ammonia on phosphorylation of microtubule-associated protein 2 (MAP-
2) in intact neurons in culture and to assess whether modulation of MAP-2 p
hosphorylation by glutamate receptor-associated transduction pathways is al
tered in neurons chronically exposed to ammonia. It is shown that chronic e
xposure to ammonia increases basal phosphorylation of MAP-2 by similar to 7
0%. This effect seems to be due to a decreased tonic activation of NMDA rec
eptors and of calcineurin. Chronic exposure to ammonia also alters the modu
lation of MAP-2 phosphorylation by NMDA receptors and metabotropic glutamat
e receptors. In neurons exposed to ammonia, treatment with NMDA for 30 min
induced a significant decrease in phosphorylation of MAP-2. Activation of m
etabotropic glutamate receptors with (1S,3R)-1 -aminocyclopentane-1,3-dicar
boxylic acid significantly increased phosphorylation of MAP in control neur
ons, whereas in neurons exposed to ammonia the response was the opposite, w
ith 1-aminocyclopentane-1,3-dicarboxylic acid inducing a dephosphorylation
of MAP-2. These results indicate that ammonia alters significantly signal t
ransduction pathways associated with different types of glutamate receptors
. This would lead therefore to significant alterations in glutamatergic neu
rotransmission, which would contribute to the neurological alterations foun
d in hyperammonemia and in hepatic encephalopathy.